Back to search

Aristotle University Of Thessaloniki (AUTH)

Μελέτη των οφθαλμολογικών επιπτώσεων των συνήθων χημειοθεραπευτικών σχημάτων που εφαρμόζονται στον καρκίνο του μαστού

Abstract

dc:description

The purpose of the present study was to evaluate possible ocular abnormalities in women with early stage breast cancer in relation to chemotherapy. 82 consecutive early stage breast cancer women aged from 25 to 78 (mean 57.93±13.02 years of age) were recruited for this study. All underwent mastectomy and after the operation all underwent adjuvant therapeutic treatment with the FEC regimen (5-Fluorouracil 600 mg/m², Epirubicin 60-90 mg/m², Cyclophosphamide 600 mg/m²). They were taking the regimen every 21 days, for 6 therapeutic cycles. All women (164 eyes) had a thorough eye examination and were free of symptoms and disease affecting vision, ocular surface and lids and also tear secretion and tear film stability, intraocular pressure and color vision. None of them had prior or coexisting treatment with other chemotherapeutic agent or radiotherapy. Slit lamp examination of the ocular surface, Schirmer test I (without topical anesthesia) and tears Break up Time test (BUT) were performed before the initiation of the chemotherapy and immediately after the third therapeutic cycle. From 61 women 9.75% had minor refractive changes. The 13.41% of the women had partial loss of eyelashes. 39.3% had significant conjunctival hyperemia, 17.07% % abnormalities of the eyelid margin, 4.88% blepharitis, 6.56% loss of eyelashes, 4.88 % punctate epithelial keratopathy and 4.87% oedema of lower punctum mucosa after the third chemotherapeutic cycle. Mean BUT values were statistically significantly lower after the third chemotherapeutic cycle but mean Schirmer test I values were statistically significantly higher. Bilateral increase of IOP above the normal range was observed in one woman. There were no changes in visual acuity of women, although in some women, a slight change in refraction was observed. No changes of iris and choroidal nevus were observed after the third chemotherapeutic treatment. In conclusion, women under chemotherapy with the FEC regimen tend to develop ocular surface and lacrimal abnormalities after the third chemotherapeutic cycle and thus ophthalmological consultation is necessary.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Karamitsos, Athanasios
  • Καραμήτσος, Αθανάσιος

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/33182

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Karamitsos, Athanasios; Καραμήτσος, Αθανάσιος. Μελέτη των οφθαλμολογικών επιπτώσεων των συνήθων χημειοθεραπευτικών σχημάτων που εφαρμόζονται στον καρκίνο του μαστού. Aristotle University Of Thessaloniki (AUTH), 2011. http://hdl.handle.net/10442/hedi/33182